Biotron Limited (Biotron) is engaged in the funding and management of intermediate and early applied biotechnology research and development projects. During the fiscal year ended June 30, 2007 (fiscal 2007), the Company completed the Phase I human clinical trial of BIT225. Biotron’s BIT225 specifically targets Human Immunodeficiency Virus (HIV) in the viral reservoirs immune cells where the virus hides for long periods when the patient otherwise seems to be carrying negligible viral loads. (Source: ARS)
Echelon Biosciences Inc., a Salt Lake City based biotechnology company with 20 employees, is engaged in furthering the science of lipid cell signalling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections, and cardiovascular disease. The focus is also on small molecule agonists and antagonists to lipid-protein signalling interactions which are new and important therapeutic targets. Furthermore, Echelon markets chemical reagents.
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory